LTIP338A - Composition for stabilizing blood plasma during pasteurisation and pasteurized plasma solution for therapeutic use - Google Patents
Composition for stabilizing blood plasma during pasteurisation and pasteurized plasma solution for therapeutic useInfo
- Publication number
- LTIP338A LTIP338A LTIP338A LTIP338A LTIP338A LT IP338 A LTIP338 A LT IP338A LT IP338 A LTIP338 A LT IP338A LT IP338 A LTIP338 A LT IP338A LT IP338 A LTIP338 A LT IP338A
- Authority
- LT
- Lithuania
- Prior art keywords
- composition
- plasma
- therapeutic use
- pasteurized
- blood plasma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a composition intended to stabilise blood plasma during pasteurisation, the blood plasma being whole or devoid of cryoproteins. The composition according to the invention makes it possible to pasteurise very large quantities of plasma (of the order of 60 litres). The invention also relates to the method for pasteurisation of the plasma using the stabilising composition. The pasteurised plasma obtained is intended for therapeutic use.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9201604A FR2687317B1 (en) | 1992-02-13 | 1992-02-13 | COMPOSITION FOR STABILIZING BLOOD PLASMA DURING PASTEURIZATION AND PASTEURIZED PLASMATIC SOLUTION FOR THERAPEUTIC USE. |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP338A true LTIP338A (en) | 1994-08-25 |
LT3226B LT3226B (en) | 1995-04-25 |
Family
ID=9426597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP338A LT3226B (en) | 1992-02-13 | 1993-02-12 | Composition for stabilizing blood plasma during pasteurisation and pasteurized plasma solution for therapeutic use |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0556096B1 (en) |
JP (2) | JP4010573B2 (en) |
AT (1) | ATE171074T1 (en) |
BR (1) | BR9300524A (en) |
CA (1) | CA2089446C (en) |
CZ (1) | CZ285573B6 (en) |
DE (1) | DE69321007T2 (en) |
DK (1) | DK0556096T3 (en) |
EE (1) | EE03091B1 (en) |
ES (1) | ES2121065T3 (en) |
FI (1) | FI103380B (en) |
FR (1) | FR2687317B1 (en) |
HU (1) | HU210026B (en) |
LT (1) | LT3226B (en) |
LV (1) | LV10195B (en) |
NO (1) | NO306532B1 (en) |
PL (1) | PL174098B1 (en) |
RU (1) | RU2112522C1 (en) |
SK (1) | SK280665B6 (en) |
UA (1) | UA27102C2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9501189D0 (en) * | 1995-03-31 | 1995-03-31 | Pharmacia Ab | Protein formulation |
US5616159A (en) * | 1995-04-14 | 1997-04-01 | Corning Incorporated | Method of forming high purity fused silica having high resistance to optical damage |
US6619073B2 (en) | 1996-03-05 | 2003-09-16 | Corning Incorporated | Method of increasing the initial transmittance of optical glass |
US6114107A (en) * | 1996-06-14 | 2000-09-05 | Biostore New Zealand Limited | Composition comprising raffinose, TMAO, sodium citrate and methods for the preservation of living tissues |
US5827640A (en) * | 1996-06-14 | 1998-10-27 | Biostore New Zealand Limited | Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose |
US6037116A (en) * | 1996-06-14 | 2000-03-14 | Biostore New Zealand, Ltd. | Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials |
US6361933B1 (en) | 1996-06-14 | 2002-03-26 | Biostore New Zealand Limited | Solutions for the preservation of tissues |
US5879875A (en) * | 1996-06-14 | 1999-03-09 | Biostore New Zealand | Compositions and methods for the preservation of living tissues |
US5962213A (en) * | 1996-06-14 | 1999-10-05 | Biostore New Zealand Limited | Compositions and methods for the preservation of living tissues |
WO1997047192A1 (en) * | 1996-06-14 | 1997-12-18 | Biostore New Zealand Limited | Compositions and methods for the preservation of living tissues |
US6915665B2 (en) | 2000-10-31 | 2005-07-12 | Corning Incorporated | Method of inducing transmission in optical lithography preforms |
US20060019234A1 (en) * | 2004-07-22 | 2006-01-26 | Shanbrom Technologies, Llc | Modern blood banking employing improved cell preservation composition |
ES2264403B1 (en) * | 2006-06-22 | 2007-11-01 | Grifols S.A. | HEMATIES SUSPENSION MEDIA. |
DE102011056142A1 (en) * | 2011-12-07 | 2013-06-13 | Manfred Rüdinger | Metabolizable salts and their use in diagnostics and therapy |
RU2639446C1 (en) * | 2016-11-23 | 2017-12-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Ярославский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method for storage of blood plasma containing drugs with unstable phenolic hydroxiles |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045153A1 (en) * | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | METHOD FOR THE PRODUCTION OF BLOOD COagulation FACTORS AND THE PREPARATION OF FACTORS IX AND X THEREFORE PRODUCED |
DE3230849A1 (en) * | 1982-08-19 | 1984-02-23 | Behringwerke Ag, 3550 Marburg | PASTEURIZED HUMAN FIBRINOGEN (HF) AND METHOD FOR THE PRODUCTION THEREOF |
DE3237512A1 (en) * | 1982-10-09 | 1984-04-12 | Behringwerke Ag, 3550 Marburg | METHOD FOR PASTEURIZING ANTIHAEMOPHILIC CRYOPRAEZIPITATE (AHK) AND ANTIHAEMOPHILE CRYOPRAECIPITATE PRODUCED THEREOF |
US4470968A (en) * | 1983-01-13 | 1984-09-11 | Miles Laboratories, Inc. | Pasteurized therapeutically active blood coagulation factor concentrates |
JPS59134730A (en) * | 1983-01-20 | 1984-08-02 | Green Cross Corp:The | Heat treatment of viii factor of blood clotting |
DE3330770A1 (en) * | 1983-08-26 | 1985-03-14 | Behringwerke Ag, 3550 Marburg | METHOD FOR PASTEURIZING HUMAN PLASMA |
FR2650508A1 (en) * | 1989-08-01 | 1991-02-08 | Fondation Nale Transfusion San | PASTEURIZED ADHESIVE FOR JOINING HUMAN OR ANIMAL TISSUES |
FR2664165B1 (en) | 1990-07-03 | 1992-10-16 | Lille Transfusion Sanguine | COMPOSITION FOR STABILIZING BLOOD PLASMA DURING PASTEURIZATION. |
-
1992
- 1992-02-13 FR FR9201604A patent/FR2687317B1/en not_active Expired - Fee Related
-
1993
- 1993-02-04 EP EP93400279A patent/EP0556096B1/en not_active Expired - Lifetime
- 1993-02-04 DE DE69321007T patent/DE69321007T2/en not_active Expired - Lifetime
- 1993-02-04 ES ES93400279T patent/ES2121065T3/en not_active Expired - Lifetime
- 1993-02-04 AT AT93400279T patent/ATE171074T1/en not_active IP Right Cessation
- 1993-02-04 DK DK93400279T patent/DK0556096T3/en active
- 1993-02-09 CZ CZ93161A patent/CZ285573B6/en not_active IP Right Cessation
- 1993-02-09 BR BR9300524A patent/BR9300524A/en not_active Application Discontinuation
- 1993-02-10 LV LVP-93-113A patent/LV10195B/en unknown
- 1993-02-10 SK SK82-93A patent/SK280665B6/en not_active IP Right Cessation
- 1993-02-11 NO NO930473A patent/NO306532B1/en not_active IP Right Cessation
- 1993-02-11 PL PL93297699A patent/PL174098B1/en not_active IP Right Cessation
- 1993-02-12 JP JP04609393A patent/JP4010573B2/en not_active Expired - Fee Related
- 1993-02-12 FI FI930630A patent/FI103380B/en not_active IP Right Cessation
- 1993-02-12 HU HU9300377A patent/HU210026B/en not_active IP Right Cessation
- 1993-02-12 LT LTIP338A patent/LT3226B/en not_active IP Right Cessation
- 1993-02-12 CA CA002089446A patent/CA2089446C/en not_active Expired - Fee Related
- 1993-06-15 UA UA93002940A patent/UA27102C2/en unknown
-
1994
- 1994-05-23 EE EE9400005A patent/EE03091B1/en not_active IP Right Cessation
-
1998
- 1998-02-12 RU RU93004727A patent/RU2112522C1/en not_active IP Right Cessation
-
2006
- 2006-08-02 JP JP2006211141A patent/JP4472672B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTIP338A (en) | Composition for stabilizing blood plasma during pasteurisation and pasteurized plasma solution for therapeutic use | |
EP0354395A3 (en) | Intramedullary rod targetting device | |
AU7253387A (en) | Fruit juice beverages and juice concentrates nutritionally supplemented with calcium | |
AU587365B2 (en) | Pasteurized human fibrinogen (HF), a process for its preparation and its use | |
EP0552240A4 (en) | New method of treating depression | |
RU93004727A (en) | COMPOSITION FOR STABILIZING BLOOD PLASMA, METHOD FOR PASTERIZING PLASMA AND USING STABILIZED PLASMA IN THERAPY | |
PL294037A1 (en) | Composition for stabilizing blood plsma during pasteurization | |
AU3881889A (en) | Human interferon-gamma, process to prepare said human interferon-gamma, and its use | |
GB8630697D0 (en) | Compositions of matter | |
EP0376608A3 (en) | Benzamide derivatives as antiarrhythmics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 20110212 |